Search results for: Health Policy and Regulation
Filter search results
Plan For A New EU Pharmaceutical Legislation: What Will It Mean For Pharmaceutical Innovation?
12 April 2024
…1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006. Available at: https://health.ec.europa.eu/system/files/2023-04/com_2023_193_1_act_en.pdf [Accessed 4 May 2023]. European Federation of Pharmaceutical…
Digital Health
…capabilities in underserved areas, and promoting personalized healthcare approaches, Digital Health significantly impacts healthcare delivery, potentially reshaping the global landscape of public health. Health Economics and digital health? Health economics…
The broader economic benefits of COVID-19 vaccination
13 October 2025
…UK, Australia and Japan) and at-risk groups, aligned with 2023/2024 national recommendations [1], prevents significant healthcare costs and pressure. Based on 2023/2024 recommendations, COVID-19 vaccination programs reduce healthcare burden by preventing…
What is the impact of Uniform Pricing, Indication-Based Pricing (IBP) and alternative commercial arrangements for new pharmaceuticals in the UK NHS?
19 November 2024
…timing and topic, and its explicit relevance to this live and evolving policy question, we summarise the EEPRU paper’s analysis in this article and offer a short critique, outlining the…
Let’s talk about (health) inequalities
1 April 2022
…for a better mechanism to inform decisions in the UK and elsewhere? Applied Health Economics and Health Policy, 19(5), pp.635-644. DOI: 10.1007/s40258-021-00648-2 Asada, Y., Abel, H., Skedgel, C. and Warner,…
The Economics of Health in a Shifting Climate: Insights from the 2023 Annual Lecture
26 September 2023
As part of OHE’s charitable purpose to educate and inform health policymakers and the public, the OHE Annual Lecture is an opportunity to highlight urgent and important issues facing health…
OHE’s AMR consultation response
21 November 2023
…across 17 criteria that cover aspects of clinical effectiveness, global and national needs, pharmacological benefits, and health system benefits. Each criterion is associated with scores and a weight (Figure 1)…
Understanding societal preferences for priority by disease severity in England & Wales
14 November 2024
…for more severe diseases in England and Wales. Members of the general population give priority at a substantially lower severity threshold, and the public assigns greater relative value to health…
Breaking the European Deadlock: Part 2 – Transferable Exclusivity Vouchers – Effective Pull Incentive or a Policy Distraction?
4 January 2024
…be low. Benefits and weaknesses of TEVs and of the European Commission’s proposals The TEV proposal has been controversial and we set out the arguments for and against drawing on…